Abiopharma

🔍 Jayaraman Vivek K (Executive)

Company: CERUS CORP (CERS)

Report Date: 2026-03-05

Detailed Transactions and Holdings:

• Acquired 80,320 shares of Common Stock (Direct)
  Date: 2026-03-05 | Code: A | equity_swap_involved: false | shares_owned_after: 1,946,968.00 | transaction_form_type: 4
• Sold 34,094 shares of Common Stock at $2.0055 per share (Direct)
  Date: 2026-03-06 | Code: S | equity_swap_involved: false | shares_owned_after: 1,912,874.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person.
• F2: Represents a weighted average sales price. These shares were sold in a block trade per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold pursuant to such block trade.